Fred Alger Management, LLC Rapt Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $1.6 Million - $3.62 Million	142,028 Added 165.58%	227,803 $5.66 Million
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $1.19 Million - $1.79 Million	-72,667 Reduced 45.86%	85,775 $1.43 Million
Q2 2023 Aug 14, 2023	SELL	$16.06 - $21.61 $611,034 - $822,195	-38,047 Reduced 19.36%	158,442 $2.96 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $3.27 Million - $5.86 Million	190,320 Added 3085.1%	196,489 $3.61 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $100,431 - $151,757	6,169 New	6,169 $122,000

105

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.